Skip to Main Content
Table 1.

Evidence for the use of broader antifungal prophylaxis agents in childhood AML

Evidence for the use of broader antifungal prophylaxis agents in childhood AML
Evidence for the use of broader antifungal prophylaxis agents in childhood AML

PC indicates prospective cohort; SCT, stem cell transplantation for leukemia; and MDS, myelodysplastic syndrome.

Close Modal

or Create an Account

Close Modal
Close Modal